title: Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
authors.forename: Asahi
authors.initials: A
authors.lastname: Hishida
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Hamajima
authors.forename: Hiroji
authors.initials: H
authors.lastname: Iwata
authors.forename: Keitaro
authors.initials: K
authors.lastname: Matsuo
authors.forename: Kaoru
authors.initials: K
authors.lastname: Hirose
authors.forename: Nobuhiko
authors.initials: N
authors.lastname: Emi
authors.forename: Kazuo
authors.initials: K
authors.lastname: Tajima
mesh_terms: D000483:Alleles; D044466:Asian People / Q000235:genetics*; D001943:Breast Neoplasms / Q000235:genetics*; D016022:Case-Control Studies; D005260:Female; D018734:Genes, erbB-2; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D007532:Isoleucine / Q000235:genetics; D007564:Japan; D016017:Odds Ratio; D011110:Polymorphism, Genetic; D011159:Population Surveillance; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*; D018570:Risk Assessment; D012307:Risk Factors; D014633:Valine / Q000235:genetics
chemical_list: D007532:Isoleucine; D018719:Erb-b2 Receptor Tyrosine Kinases; D014633:Valine